Clinigen reveals strategy in bid to become the Amazon of hard-to-access drugs
Clinigen (CLIN:AIM)Gain to date: 0.1%Original entry point: Buy at 865p, 11 October 2018We are flummoxed by speciality pharma firm Clinigen's (CLIN:AIM) lack of share price momentum as it pursues an ambitious strategy in a bid to...
06 December 2018